Such behavior is further modulated by intrinsic cellular features, including cell cycle heterogeneity, receptor saturation, transcriptional feedback, and interindividual genetic variability, as previously reported in fibroblasts from systemic sclerosis patients and in studies of IL‐6 promoter polymorphisms [35, 36]. This evidence concerns the gene IL6 and systemic sclerosis.